CIK 0000948320 · Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760238453
- Phone
- (866) 351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-06 | DiTrolio Joseph Director | Grant or award | +8,000 | 251,048 | ||
| 2024-12-02 | Simon Roberto Director | Grant or award | +50,000 | 150,000 | ||
| 2024-12-02 | Simon Roberto Director | Grant or award | +6,162 | 156,162 | ||
| 2024-12-02 | Simon Roberto Director | Grant or award | +24,648 | 180,810 | ||
| 2024-12-02 | Simon Roberto Director | Grant or award | +30,000 | 130,000 | ||
| 2024-12-02 | Simon Roberto Director | Grant or award | +6,162 | 136,162 | ||
| 2024-12-02 | Simon Roberto Director | Grant or award | +24,648 | 160,810 | ||
| 2024-12-02 | Strawn John R Jr Director | Grant or award | +30,000 | 363,347 | ||
| 2024-12-02 | Strawn John R Jr Director | Grant or award | +2,641 | 365,988 | ||
| 2024-12-02 | Strawn John R Jr Director | Grant or award | +24,648 | 390,636 | ||
| 2024-12-02 | Schreiber Justin Chief Executive Officer | Sale 10b5-1 | −25,000 | $6.52 | $163K | 2,728,715 |
| 2024-12-02 | Schreiber Justin Chief Executive Officer | Other acquisition 10b5-1 | +0 | 200,000 | ||
| 2024-09-11 | Galluppi Stefan Chief Innovation Officer | Purchase | +3,000 | $4.93 | $15K | 45,449 |
| 2024-08-18 | Wijnker Dennis Chief Technology Officer | Grant or award | +80,000 | 100,000 | ||
| 2024-08-18 | Wijnker Dennis Chief Technology Officer | Returned to the company · Stock Option (Right to Buy) | −80,000 | 0 | ||
| 2024-07-17 | Jindal Piyush Director | Grant or award | +24,835 | 362,335 | ||
| 2024-04-26 | MACRAE CALUM ARCHIBALD Director | Grant or award | +16,500 | 16,500 | ||
| 2024-04-04 | BHATIA NAVEEN Director | Other acquisition | +500 | 488,599 | ||
| 2024-03-21 | Yecies Eric Harold General Counsel & CCO | Grant or award | +56,250 | 271,250 | ||
| 2024-03-21 | STAN MARIA E. Principal Accounting Officer | Grant or award | +20,000 | 28,125 |
Page 4 of 8 · 146 trades